Palantir Is Growing at a Jaw-Dropping Rate, but Is the Stock a Buy?

Palantir reported Q1 revenue growth of 85% year over year, with commercial revenue up 104% and a GAAP profit margin of 53%. The article argues the stock remains expensive at about 93x forward earnings and 154x trailing earnings, implying years of growth are already priced in. Overall stance is constructive on the business but bearish on valuation, with the author recommending investors avoid the stock.

Analysis

PLTR is increasingly behaving like a duration asset disguised as a software stock: the market is not paying for this quarter, it is capitalizing a multi-year operating system land grab. The issue is that once a software name reaches this mix of growth + margin, incremental upside usually comes from either a second inflection in addressable market or a sharp re-rating in unit economics; neither is obvious here. That makes the base case less about fundamental deterioration and more about multiple compression if growth merely normalizes from hyper-growth to high-growth.

The second-order dynamic is competitive pressure on adjacent enterprise AI workflows. A richly valued PLTR tends to pull budget attention toward “platform” spend, which can help NVDA indirectly via continued model/inference demand, but it also raises the bar for other application-layer AI vendors that are still subsidizing growth. In contrast, INTC is largely irrelevant to the thesis except as a reminder that capital allocates toward proven AI monetizers, not turnaround stories.

Near term, the stock is vulnerable to even small disappointments because the setup leaves little room for estimate revision misses, slower commercial deal conversion, or margin giveback from sales/implementation expense. The time horizon that matters is months, not days: a few prints of decelerating growth or an AI spending pause could compress the multiple materially before the business weakens. The contrarian miss in consensus is that “great company” and “good stock” have already diverged; at this valuation, PLTR needs continued perfection, not just excellence.

The cleaner expression is not to short the company outright but to fade the multiple versus higher-quality AI exposure. If PLTR keeps compounding at a strong clip, downside should be buffered by fundamentals, but if growth normalizes, the stock can rerate quickly without a catastrophic earnings miss. That asymmetry favors pairs and options over directional shorting.

Key Decisions for Investors

• Short PLTR vs long NVDA as a relative-value pair for the next 1-3 quarters: NVDA has better support from secular AI capex and a materially lower forward multiple, while PLTR needs repeated beats to justify its premium.
• Buy PLTR put spreads 3-6 months out on any post-earnings strength: structure for a 15-25% downside move if the market starts discounting growth normalization; risk is limited to premium paid.
• Avoid initiating new long PLTR positions until valuation resets or growth reaccelerates for another quarter: the current setup has poor asymmetry, with limited upside and large multiple-compression risk.
• Use NVDA as the cleaner long in AI software/infrastructure baskets: it benefits from broad AI adoption without relying on enterprise platform adoption rates to sustain a premium multiple.
• If already long PLTR, trim 25-50% into strength and retain only a core position for optionality: this reduces exposure to a valuation air-pocket while preserving upside if the platform thesis extends.